VP (Direction of New Drug Transformation)

2023-06-06

Responsibilities

1. Responsible for the preclinical research of the company's innovative drugs and the organization and management of phase I clinical trials, including: the establish/manage/evaluate the company's animal experimental research program in the screening stage of research projects; Establish preclinical study protocols and communicate/supervise with preclinical CRO institutions; Prepare and manage new drug application and approval data (preclinical part); Establish phase 1 clinical protocol and communicate/supervise clinical CRO institutions;

2. Participate in the project investigation, decision-making and project management of the company's innovative biological drug R&D, involved in tumor (TCB, ADC), metabolic (diabetes, obesity, non-alcoholic fatty liver and related), neovascularization (tumor, ophthalmology) and other fields;

3. Participate in international cooperation management such as product authorization or project introduction;

4. Participate in the preparation of IND materials for biological drugs (domestic and international).

Job requirements

1.Major in biology/pharmacology/clinical medicine or related, master degree or higher;

2. Familiar with preclinical and clinical trial process of drugs, and familiar with GCP, FDA and other industry standards and regulations and policies;

3. Excellent English listening, speaking, reading and writing skills;

4. Strong team leadership, excellent organization and planning skills, and good interpersonal skills;

5. At least 4-year working experience in pharmaceutical manufacturing or CRO company, at least in charge of 2 preclinical or clinical trial projects, experience in joint venture or multinational company is preferred, experience in metabolic/ophthalmic/oncology drug clinical trials, at least 5-year working experience in biologic drug development, research background in pharmaceutical industry is preferred;

6. Remuneration: annual salary + project stage incentive + equity incentive.